Cushing's syndrome trials in Austria

1 of 1 trials · From EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Not yet taking people in Austria
  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  Where

  Graz, Vienna

  Age

  18 years and over

  People

  97 worldwide

  Run by

  Crinetics Pharmaceuticals Inc.

  See details and how to join2025-522648-42-01